Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
495.6 GBX | +2.19% | +1.44% | -7.62% |
22/04 | Berenberg Trims Phoenix Group PT, Maintains Buy Rating | MT |
22/04 | Phoenix Group Hires BHM Capital as Liquidity Provider on Abu Dhabi Bourse | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The stock, which is currently worth 2024 to 0.53 times its sales, is clearly overvalued in comparison with peers.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 253.4 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.62% | 6.03B | A- | ||
+16.21% | 79.51B | B- | ||
+8.29% | 50.22B | B+ | ||
+2.56% | 48.11B | B | ||
+10.48% | 42.2B | B+ | ||
+8.01% | 39.71B | B+ | ||
+20.13% | 37.78B | B | ||
+3.10% | 30.07B | B | ||
-7.75% | 27.56B | B- | ||
-16.46% | 24.71B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PHNX Stock
- Ratings Phoenix Group Holdings plc